Case Report | | Peer-Reviewed

A Novel Nonsense Homozygous Mutation in SMARCD2 Gene Causing Specific Granulocyte Deficiency Type 2: Case Report

Received: 3 December 2024     Accepted: 19 December 2024     Published: 31 December 2024
Views:       Downloads:
Abstract

Background: Specific granulocyte deficiency type 2(SGD2) is a rare disorder of neutrophil defect caused by mutation in SMARCD2 gene characterized by neutropenia, recurrent infections, skin and mucosal ulceration. Objective: We aim to describe a symptomatic patient with a novel homozygous nonsense variant in SMARCD2 to help expand the phenotypic description of this rare disease. Methods: A retrospective chart review was conducted on our patient. Data collection included information on demographic, clinical and laboratory data. Results: We report a 4 years old boy with history of delayed separation of cord, recurrent sepsis, skin infections as well as mucocutaneous ulceration, gastrointestinal bleeding and Epstein Barr virus induced lymphoproliferation. He had variable neutropenia, bone marrow biopsy revealed hypogranular neutrophils and no blast excess. Whole genome analysis detected a novel homozygous variant in SMARCD2 gene c.208C > T p.(Gln70*). Conclusion: This case report aims to provide insight on additional clinical and molecular features of SGD2. It also sheds light on potential role of SMARCD2 gene in other immune cells.

Published in International Journal of Immunology (Volume 12, Issue 4)
DOI 10.11648/j.iji.20241204.11
Page(s) 52-58
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Inborn Errors of Immunity, Neutropenia, SMARCD2, Specific Granulocyte Deficiency

References
[1] Witzel, M., Petersheim, D., Fan, Y., Bahrami, E., Racek, T., Rohlfs, M., Puchałka, J., Mertes, C., Gagneur, J., Ziegenhain, C., Enard, W., Stray-Pedersen, A., Arkwright, P. D., Abboud, M. R., Pazhakh, V., Lieschke, G. J., Krawitz, P. M., Dahlhoff, M., Schneider, M. R., & Wolf, E. Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytes. Nature Genetics. 2017, 49(5), 742–752.
[2] Schim, I., Evelien G. G. Sprenkeler, Anton T. J. Tool, Abinun, M., Grainger, A., Engelhardt, K. R., Michel van Houdt, Janssen, H., Kuijpers, T. W., & Hambleton, S. Defective neutrophil development and specific granule deficiency caused by a homozygous splice-site mutation in SMARCD2. The Journal of Allergy and Clinical Immunology. 2021, 147(6), 2381-2385. e2.
[3] Kihtir, Z., Çelik, K., Tayfun Küpesiz, F., Küpesiz, O. A., Kocacik Uygun, D. F., Arayici, S., Ongun, H., Acarbulut, İ., Sağlam, C., Ceylaner, G., & Bingöl, A. Specific Granule Deficiency Due To Novel Homozygote SMARCD2 Variant. Pediatric Allergy, Immunology, and Pulmonology. 2022, 35(1), 43–46.
[4] Esra Yücel, İbrahim Serhat Karakuş, Krolo, A., Ayça Kıykım, Raúl Jimenez Heredia, Tamay, Z., Funda Çipe, Elif Karakoç-Aydıner, Ahmet Özen, Karaman, S., Kaan Boztuğ, & Safa Barış. Novel Frameshift Autosomal Recessive Loss-of-Function Mutation in SMARCD2 Encoding a Chromatin Remodeling Factor Mediates Granulopoiesis. Journal of Clinical Immunology. 2020, 41(1), 59–65.
[5] Ibrahim, A., Anjali Sharathkumar, McLaughlin, H., Claassen, D. A., & Sharathkumar Bhagavathi. Congenital Neutropenia with Specific Granulocyte Deficiency Caused by Novel Double Heterozygous SMARCD2 Mutations. Hematology Reviews. 2022, 14(3), 270–275.
[6] Ali, A., Tabouni, M., Praseetha Kizhakkedath, Baydoun, I., Allam, M., John, A., Faiza Busafared, Alnuaimi, A., Fatma Al-Jasmi, & Hiba Alblooshi. Spectrum of genetic variants in bilateral sensorineural hearing loss. Frontiers in Genetics. 2024, 15.
[7] Stenson, P. D., Ball, E. V., Mort, M., Phillips, A. D., Shiel, J. A., Thomas, N. S. T., Abeysinghe, S., Krawczak, M., & Cooper, D. N. Human Gene Mutation Database (HGMD®): 2003 update. Human Mutation. 2003, 21(6), 577–581.
[8] Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., Gauthier, L. D., Brand, H., Solomonson, M., Watts, N. A., Rhodes, D., Singer-Berk, M., England, E. M., Seaby, E. G., Kosmicki, J. A., & Walters, R. K. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020, 581(7809), 434–443.
[9] Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., & Rehm, H. L. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine: Official Journal of the American College of Medical Genetics. 2015, 17(5), 405–424.
[10] GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science (New York, N. Y.). 2015, 348(6235), 648–660.
[11] Priam, P., Krasteva, V., Rousseau, P., D’Angelo, G., Gaboury, L., Sauvageau, G., & Lessard, J. A. SMARCD2 subunit of SWI/SNF chromatin-remodeling complexes mediates granulopoiesis through a CEBPɛ dependent mechanism. Nature Genetics. 2017, 49(5), 753–764.
[12] Ruo Ran Wang, Pan, R., Zhang, W., Fu, J., Lin, J. D., & Zhuo Xian Meng. The SWI/SNF chromatin-remodeling factors BAF60a, b, and c in nutrient signaling and metabolic control. Protein & Cell. 2017, 9(2), 207–215.
[13] Cohen, J. I., & Meyts, I. Editorial: EBV Infection and Human Primary Immune Deficiencies. Frontiers Immunology. 2020, 11.
[14] Ru, Y., Chen, J., & Wu, D. Epstein‐Barr virus post‐transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation. European Journal of Haematology. 2018, 101(3), 283–290.
[15] Sharma, S., Rakesh Kumar Pilania, Gummadi Anjani, Sudhakar, M., Arora, K., Tyagi, R., Dhaliwal, M., Pandiarajan Vignesh, Rawat, A., & Singh, S. Lymphoproliferation in Inborn Errors of Immunity: The Eye Does Not See What the Mind Does Not Know. Frontiers in Immunology. 2022, 13.
[16] Colucci, M., Carsetti, R., Serafinelli, J., Rocca, S., Massella, L., Gargiulo, A., Lo Russo, A., Capponi, C., Cotugno, N., Porzio, O., Onetti Muda, A., Palma, P., Emma, F., & Vivarelli, M. Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome. Frontiers in Immunology. 2019, 10.
[17] Makatsori, M., Kiani-Alikhan, S., Manson, A. L., Verma, N., Leandro, M., Gurugama, N. P., Longhurst, H. J., Grigoriadou, S., Buckland, M., Kanfer, E., Hanson, S., Ibrahim, M. A. A., Grimbacher, B., Chee, R., & Seneviratne, S. L. Hypogammaglobulinaemia after rituximab treatment--incidence and outcomes. QJM. 2014, 107(10), 821–828.
[18] Fournier, B. M., & Parkos, C. A. The role of neutrophils during intestinal inflammation. Mucosal Immunology. 2012, 5(4), 354–366.
[19] Yamamoto-Furusho, J. K. (2006). Crohn’s disease: Innate immunodeficiency? World Journal of Gastroenterology, 12(42), 6751.
Cite This Article
  • APA Style

    Kuwaiti, A. A. A., Awadi, H. A., Kizhakkedath, P., Baydoun, I., Tabouni, M., et al. (2024). A Novel Nonsense Homozygous Mutation in SMARCD2 Gene Causing Specific Granulocyte Deficiency Type 2: Case Report. International Journal of Immunology, 12(4), 52-58. https://doi.org/10.11648/j.iji.20241204.11

    Copy | Download

    ACS Style

    Kuwaiti, A. A. A.; Awadi, H. A.; Kizhakkedath, P.; Baydoun, I.; Tabouni, M., et al. A Novel Nonsense Homozygous Mutation in SMARCD2 Gene Causing Specific Granulocyte Deficiency Type 2: Case Report. Int. J. Immunol. 2024, 12(4), 52-58. doi: 10.11648/j.iji.20241204.11

    Copy | Download

    AMA Style

    Kuwaiti AAA, Awadi HA, Kizhakkedath P, Baydoun I, Tabouni M, et al. A Novel Nonsense Homozygous Mutation in SMARCD2 Gene Causing Specific Granulocyte Deficiency Type 2: Case Report. Int J Immunol. 2024;12(4):52-58. doi: 10.11648/j.iji.20241204.11

    Copy | Download

  • @article{10.11648/j.iji.20241204.11,
      author = {Amna Ali Al Kuwaiti and Haifa Al Awadi and Praseetha Kizhakkedath and Ibrahim Baydoun and Mohammed Tabouni and Hiba Alblooshi and Fatma Al-Jasmi and Aisha Al Shamsi and Hiba Mohammed Shendi},
      title = {A Novel Nonsense Homozygous Mutation in SMARCD2 Gene Causing Specific Granulocyte Deficiency Type 2: Case Report
    },
      journal = {International Journal of Immunology},
      volume = {12},
      number = {4},
      pages = {52-58},
      doi = {10.11648/j.iji.20241204.11},
      url = {https://doi.org/10.11648/j.iji.20241204.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.iji.20241204.11},
      abstract = {Background: Specific granulocyte deficiency type 2(SGD2) is a rare disorder of neutrophil defect caused by mutation in SMARCD2 gene characterized by neutropenia, recurrent infections, skin and mucosal ulceration. Objective: We aim to describe a symptomatic patient with a novel homozygous nonsense variant in SMARCD2 to help expand the phenotypic description of this rare disease. Methods: A retrospective chart review was conducted on our patient. Data collection included information on demographic, clinical and laboratory data. Results: We report a 4 years old boy with history of delayed separation of cord, recurrent sepsis, skin infections as well as mucocutaneous ulceration, gastrointestinal bleeding and Epstein Barr virus induced lymphoproliferation. He had variable neutropenia, bone marrow biopsy revealed hypogranular neutrophils and no blast excess. Whole genome analysis detected a novel homozygous variant in SMARCD2 gene c.208C > T p.(Gln70*). Conclusion: This case report aims to provide insight on additional clinical and molecular features of SGD2. It also sheds light on potential role of SMARCD2 gene in other immune cells.
    },
     year = {2024}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - A Novel Nonsense Homozygous Mutation in SMARCD2 Gene Causing Specific Granulocyte Deficiency Type 2: Case Report
    
    AU  - Amna Ali Al Kuwaiti
    AU  - Haifa Al Awadi
    AU  - Praseetha Kizhakkedath
    AU  - Ibrahim Baydoun
    AU  - Mohammed Tabouni
    AU  - Hiba Alblooshi
    AU  - Fatma Al-Jasmi
    AU  - Aisha Al Shamsi
    AU  - Hiba Mohammed Shendi
    Y1  - 2024/12/31
    PY  - 2024
    N1  - https://doi.org/10.11648/j.iji.20241204.11
    DO  - 10.11648/j.iji.20241204.11
    T2  - International Journal of Immunology
    JF  - International Journal of Immunology
    JO  - International Journal of Immunology
    SP  - 52
    EP  - 58
    PB  - Science Publishing Group
    SN  - 2329-1753
    UR  - https://doi.org/10.11648/j.iji.20241204.11
    AB  - Background: Specific granulocyte deficiency type 2(SGD2) is a rare disorder of neutrophil defect caused by mutation in SMARCD2 gene characterized by neutropenia, recurrent infections, skin and mucosal ulceration. Objective: We aim to describe a symptomatic patient with a novel homozygous nonsense variant in SMARCD2 to help expand the phenotypic description of this rare disease. Methods: A retrospective chart review was conducted on our patient. Data collection included information on demographic, clinical and laboratory data. Results: We report a 4 years old boy with history of delayed separation of cord, recurrent sepsis, skin infections as well as mucocutaneous ulceration, gastrointestinal bleeding and Epstein Barr virus induced lymphoproliferation. He had variable neutropenia, bone marrow biopsy revealed hypogranular neutrophils and no blast excess. Whole genome analysis detected a novel homozygous variant in SMARCD2 gene c.208C > T p.(Gln70*). Conclusion: This case report aims to provide insight on additional clinical and molecular features of SGD2. It also sheds light on potential role of SMARCD2 gene in other immune cells.
    
    VL  - 12
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Sections